DCF valuation of unquoted shares cannot be replaced by NAV absent cogent reasons; share premium addition fails accordingly.

Valuation of unquoted shares under Rule 11UA(2) may be supported by a prescribed expert's discounted cash flow report, and the revenue cannot reject that method merely by preferring net asset value or by relying on later actual performance. A DCF valuation is projection-based, so it can be displaced only where the methodology or core assumptions are demonstrably and materially flawed, with recorded reasons. In the context of Section 56(2)(viib), an addition for alleged excess share premium is not sustainable where the assessee has used a permissible valuation method and the revenue fails to establish fundamental error in the valuation. The described article states that the valuation rejection and consequent addition were set aside.

---

---

Issues: (i) Whether the Assessing Officer / appellate authority could reject a valuation of unquoted shares determined by a prescribed method (discounted cash flow) and substitute or adopt an alternative valuation (NAV) when confronted with a merchant banker/chartered accountant report; (ii) Whether the addition under Section 56(2)(viib) of the Income-tax Act, 1961 arising from alleged excess share premium was sustainable.

Issue (i): Whether the revenue can reject a DCF valuation obtained from a prescribed expert and independently adopt NAV or determine FMV by its own accord.

Analysis: The statutory scheme permits the assessee to determine FMV by specified methods including a merchant banker/valuer report using DCF as recognised under Rule 11UA(2). Valuation by DCF is projection based and depends on facts and assumptions available on the valuation date. Judicial authorities recognise that valuation is not an exact arithmetic exercise and that a valuer's projections cannot be impeached solely by comparing later actuals. Where a valuation is prepared by a prescribed expert in accordance with the methods contemplated by the statute, the revenue does not possess unbridled power to substitute its own valuation method absent an enabling provision or cogent reason. Rejection of a DCF report requires demonstrable flaws in the methodology or material misstatements; mere hindsight comparison with subsequent performance is insufficient.

Conclusion: The Assessing Officer / appellate authority cannot lawfully reject a DCF valuation prepared by a prescribed expert and replace it with NAV or another valuation without recorded, legitimate grounds showing the DCF report to be demonstrably flawed.

Issue (ii): Whether the addition under Section 56(2)(viib) based on treating premium as income was justified.

Analysis: Section 56(2)(viib) is a deeming provision that applies where FMV of unquoted shares is less than the consideration received. The rule framework contemplates methods including DCF reports by prescribed experts. If the assessee adopts a permissible method and produces a valuation by a qualified valuer, and the identity and genuineness of investors are not in doubt, invoking the deeming provision to make an addition requires more than speculative or hindsight objections. Absent a demonstration that the chosen valuation method or its application was made on wholly erroneous assumptions going to the root of valuation, the addition cannot be sustained. Where valuation was accepted as per prescribed method, and no alternative fair value was determined by the revenue with reasons, the addition is unsustainable.

Conclusion: The addition under Section 56(2)(viib) is not sustainable where the assessee has produced a valuation in accordance with the prescribed method and the revenue fails to establish that the valuation was fundamentally erroneous; therefore the addition is set aside in favour of the assessee.

Final Conclusion: The authorities' rejection of the DCF valuation and substitution with NAV, and consequent addition under Section 56(2)(viib), are set aside; the appeal is allowed insofar as the valuation and addition challenged are concerned, while other grounds held to be academic are left open.

Ratio Decidendi: Where an assessee obtains a valuation of unquoted shares by a prescribed expert using a method permitted by Rule 11UA(2), the revenue may not substitute its own valuation method or compute an alternate FMV without recording cogent, supportable reasons demonstrating that the valuer's methodology or core assumptions are demonstrably and materially flawed; valuation based on projections cannot be invalidated merely by later hindsight comparison with actual results.

---